Oxidized/misfolded superoxide dismutase‐1: the cause of all amyotrophic lateral sclerosis?
- 11 December 2007
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 62 (6) , 553-559
- https://doi.org/10.1002/ana.21319
Abstract
The identification in 1993 of superoxide dismutase‐1 (SOD1) mutations as the cause of 10 to 20% of familial amyotrophic lateral sclerosis cases, which represents 1 to 2% of all amyotrophic lateral sclerosis (ALS) cases, prompted a substantial amount of research into the mechanisms of SOD1‐mediated toxicity. Recent experiments have demonstrated that oxidation of wild‐type SOD1 leads to its misfolding, causing it to gain many of the same toxic properties as mutant SOD1. In vitro studies of oxidized/misfolded SOD1 and in vivo studies of misfolded SOD1 have indicated that these protein species are selectively toxic to motor neurons, suggesting that oxidized/misfolded SOD1 could lead to ALS even in individuals who do not carry an SOD1 mutation. It has also been reported that glial cells secrete oxidized/misfolded mutant SOD1 to the extracellular environment, where it can trigger the selective death of motor neurons, offering a possible explanation for the noncell autonomous nature of mutant SOD1 toxicity and the rapid progression of disease once the first symptoms develop. Therefore, considering that sporadic (SALS) and familial ALS (FALS) cases are clinically indistinguishable, the toxic properties of mutated SOD1 are similar to that of oxidized/misfolded wild‐type SOD1 (wtSOD1), and secreted/extracellular misfolded SOD1 is selectively toxic to motor neurons, we propose that oxidized/misfolded SOD1 is the cause of most forms of classic ALS and should be a prime target for the design of ALS treatments. Ann Neurol 2007Keywords
This publication has 59 references indexed in Scilit:
- Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2007
- Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALSProceedings of the National Academy of Sciences, 2007
- Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS modelNature Neuroscience, 2007
- Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2007
- Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentialsProceedings of the National Academy of Sciences, 2006
- Antisense oligonucleotide therapy for neurodegenerative diseaseJournal of Clinical Investigation, 2006
- Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model miceProceedings of the National Academy of Sciences, 2006
- Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondriaProceedings of the National Academy of Sciences, 2006
- Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS modelProceedings of the National Academy of Sciences, 2006
- An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindredAnnals of Neurology, 2002